-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Jounce Therapeutics, Inc. annual/quarterly Depreciation history and growth rate from Q1 2016 to Q1 2022.
- Jounce Therapeutics, Inc. Depreciation for the quarter ending March 31, 2022 was $590K, a 24.8% decline year-over-year.
- Jounce Therapeutics, Inc. annual Depreciation for 2022 was $2.09M, a 26.2% decline from 2021.
- Jounce Therapeutics, Inc. annual Depreciation for 2021 was $2.83M, a 16.9% decline from 2020.
- Jounce Therapeutics, Inc. annual Depreciation for 2020 was $3.4M, a 11.7% decline from 2019.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)